Skip to main content
Department of Neurosciences Department of Neurosciences

Current Epilepsy Research Studies

Currently Enrolling Clinical Trials

New treatments cannot be widely used until they have been shown to work safely in patients, and clinical trials are the standard used to judge these treatments as safe and effective. You can search them here:
https://clinicaltrials.ucsd.edu/epilepsy 

 

EpiFOS trial: CBD for focal epilepsy

Open-label treatment of focal epilepsy with CBD oil. See patient information brochure or the health care provider information document for referring patients.

ClinicalTrials.gov registration(s): NCT07233239

PI: Taha Gholipour, MD

Sponsor: Jazz Pharmaceuticals

Study website: EpiFOS Clinical Trial

Contact:  EpilepsyCBDstudy@health.ucsd.edu 

Rise trial: new antiseizure medication for focal epilepsy


Randomized Clinical Trial followed by an Open-lebel extension trial. See Brochure for short eligibility description.

ClinicalTrials.gov registration(s): NCT06132893 and NCT06443463

PI: Taha Gholipour, MD

Sponsor: Biohaven Pharmaceuticals

Study website: Rise Clinical Trial

Contact: cbarnet@health.ucsd.edu 

 

Epilepsy Cell Therapy Trial

This is a multicenter open label clinical trial that is designed to test the safety and efficacy of inhibitory nerve cells called interneurons (NRTX-1001) administered into temporal lobes of subjects with drug-resistant mesial temporal lobe epilepsy.

UC San Diego Epilepsy Center team was one of the first centers in the country to inject regenerative cells into the brain to treat epileptic seizures.

  • A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE). For recruitement criteria, please see the page
  • Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy)). For recruitement criteria, please see this page

ClinicalTrials.gov registration(s): NCT05135091 and NCT06422923

 PI: Jerry Shih, MD

Sponsor: Neurona Therapeutics

Study website: NTE001 and NTE002 Clinical Trial

Contact: msantizo@health.ucsd.edu 

Currently Enrolling Observational Studies

Observational studies are used to follow people who may already be receiving treatment for epilepsy while measuring their outcomes. These studies rely upon a more natural setting as participants select their treatment.

 

Brain Aging and Cognition in Epilepsy (BRACE)

A longitudinal investigation of vascular, genetic, and biomarker risk profiles in older adults with epilepsy

 Older adults with epilepsy are the fastest growing segment of new cases of epilepsy.  However, very little is known about older adults with epilepsy age.  The BrACE study looks at how epilepsy affects brain and cognitive aging as people with epilepsy age. By combining brain imaging, cognitive testing, blood-based biomarkers and health information over time, the study aims to understand why some people with epilepsy experience cognitive decline while others remain resilient. The goal is to use this knowledge to improve prediction, patient care, and quality of life for people living with epilepsy as they age.

 Eligible participants: People with focal epilepsy who are over the age of 55 years and have either chronic or late-onset epilepsy and no overt history of clinical stroke.  Participants must be able to undergo an MRI scan.

UCSD IRB #210422

PI: Carrie McDonald, Ph.D.

Sponsor: National Institute of Neurological Disorders and Stroke
NIH RePORTER:  R01NS120976

Contact:  LOCIResearch@gmail.com

ENIGMA-Epilepsy: predicting treatment resistance and post-surgical outcome

Identifying brain networks to predict treatment resistance and post-surgical outcome

ENIGMA-Epilepsy is a global consortium of 38 epilepsy centers who are actively building a large, harmonized international dataset of neuroimaging, clinical, and genetic data in people with epilepsy. By pooling data from thousands of patients and controls across many countries, this grant is enabling the robust development of AI models for disease detection and outcome prediction, investigation of the neurobiological networks underlying epilepsy and the identification of imaging- and genetics-based markers that predict key clinical outcomes, including drug resistance and surgical success. The ultimate goal of this grant and the ENIGMA-Epilepsy is to generate reproducible, generalizable insights that can guide personalized treatment decisions for epilepsy worldwide.

 Eligible centers:   Any epilepsy center collecting MRI and clinical data on patients with epilepsy between 7-90 years of age.  Data may be collected through clinical centers or research programs.

 UCSD IRB # 804167

PI:  Carrie McDonald, Ph.D.

Sponsor:  National Institute of Neurological Disorders and Stroke

NIH Reporter:  R01 NS122827

Contact: LOCIResearch@gmail.com 

 

Predicting outcomes of epilepsy surgery from individualized resting state fMRI

Current clinical and imaging predictors of response to epilepsy surgery are inadequate, and surgical treatment outcomes are mixed. Predicting the seizure and non-seizure outcomes are critical for clinical decision making. Functional MRI (fMRI) offers noninvasive and accessible means to complement current methods of surgical planning to guide treatment. This project will prospectively collect resting state fMRI from focal epilepsy patients and some healthy volunteers and use new analytic methods to develop predictive models.

Eligible participants: People with focal epilepsy who are undergoing pre-surgical evaluation for open surgery, laser ablation of seizure focus, or placement of neurostimulators. 

UCSD IRB #810686

 PI: Taha Gholipour, MD

Sponsor: National Institute of Neurological Disorders and Stroke 

NIH RePORTER:  K23NS135108

Contact: gholipourlab@ucsd.edu

Multimodal imaging of memory in epilepsy

From whole brain networks to local neuronal responses: Implications for surgical decision-making

 Despite advances in epilepsy surgery and the availability of less invasive options, accurately predicting which patients will experience memory decline after surgery remains a major challenge. This study integrates structural, functional, and diffusion MRI with neuropsychological testing to estimate an individual’s risk for memory change following resective surgery or laser ablation. The goal is to develop personalized prediction tools that support informed surgical decision-making, patient counseling, and strategies to preserve cognitive outcomes. 

Eligible participants:  People 18-55 years of age with temporal lobe epilepsy who are considering a surgical intervention for seizure control.  Participants must be able to undergo MRI and complete neuropsychological testing.

UCSD IRB # 801713 

PI:  Carrie McDonald, Ph.D.

Sponsor:  National Institute of Neurological Disorders and Stroke

NIH Reporter:  R01NS124585

Contact: LOCIResearch@gmail.com 

Tracking Lifestyle and Cognitive Health in Epilepsy Using Digital Tools

This study uses brief smartphone-based cognitive tests and wearable activity monitors to track daily thinking, sleep, and lifestyle habits in adults with epilepsy. The goal is to better understand real-world cognitive changes over time and identify factors that may help support brain health in individuals with epilepsy.

Eligible participants: Adults with epilepsy across the adult lifespan, including individuals with medication-resistant epilepsy.

 UCSD IRB#: 813694

 PI: Alena Stasenko, PhD

 Sponsor: National Institute of Neurological Disorders and Stroke

 NIH RePORTER: K23NS142707

Contact email: astasenko@ucsd.edu 

Personalized neurostimulation protocol for memory mapping in epilepsy

The study aims to develop a novel method to predict post‑operative memory decline in patients with drug‑resistant temporal lobe epilepsy (TLE) by using intracranial electrical stimulation to induce transient, reversible disruptions in medial temporal lobe (MTL) function during memory testing. Leveraging standard pre‑surgical electrode implants, the project will (1) map the spatial spread of stimulation to ensure focality and interpretability, and (2) design and validate a stimulation‑paired memory testing paradigm to identify memory‑critical MTL sites. This approach aims to provide a patient‑specific functional assay to forecast cognitive risk from MTL resections or ablations, addressing a major clinical gap and directly informing surgical planning to preserve memory.

Eligible participants: People 18-65 years of age undergoing stage two intracranial electrophysiology for the purposes of surgical intervention planning for seizure control.  Participants must be undergoing electrical stimulation for seizure mapping during their phase two evaluation.

 UCSD IRB # 190599

PI: Erik Kaestner, Ph.D.

Sponsor: National Institute of Neurological Disorders and Stroke

NIH Reporter: K01NS124831 

Contact: ekaestne@health.ucsd.edu

 

 

Types of Research Procedures

For any given study, you may be asked to undergo any or all of the following procedures:

  • Structural Magnetic Resonance Image (MRI)
  • Electroencephalogram (EEG)
  • Neuropsychological Testing
  • Functional MRI
  • Magnetoencephalography (MEG) 
  • PET Scan

Find out more about research procedures available at our Epilepsy Center!